Bayer Yakuhin to Set Up Committee to Promote Proper Use of Xarelto

Bayer Yakuhin said it will set up a committee within the company consisting of external doctors to prompt the proper use of its novel oral anticoagulant Xarelto (rivaroxaban), launched on April 18, and will focus its attention on the promotion...read more